Related Experiment Videos
Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK)
A Reis1, H C Hennies, L Langbein
1Institute of Human Genetics, Free University, Berlin, Germany.
Nature Genetics
|February 1, 1994
Summary
Researchers identified three mutations in the human type I keratin 9 (KRT9) gene associated with epidermolytic palmoplantar keratoderma (EPPK). These KRT9 gene mutations provide insights into skin disease mechanisms.
Area of Science:
- Genetics
- Dermatology
- Molecular Biology
Background:
- Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominant skin disorder.
- Keratins are intermediate filament proteins crucial for skin structure and integrity.
- Human type I keratin 9 (KRT9) gene mutations are implicated in certain skin conditions.
Purpose of the Study:
- To isolate and characterize the human type I keratin 9 (KRT9) gene.
- To investigate the genetic basis of epidermolytic palmoplantar keratoderma (EPPK).
- To identify specific KRT9 mutations associated with EPPK.
Main Methods:
- Gene isolation and chromosomal localization of KRT9 to 17q21.
- Mutation screening in patients diagnosed with EPPK.
- Analysis of mutation location within the KRT9 gene's rod domain.
Main Results:
- Three novel mutations in the KRT9 gene (N160K, R162Q, R162W) were identified in EPPK patients.
- All identified mutations are located in the highly conserved coil 1A region of the rod domain.
- The R162W mutation was found in five unrelated families, suggesting a significant role in EPPK pathogenesis.
Conclusions:
- Mutations in the KRT9 gene are a cause of epidermolytic palmoplantar keratoderma.
- The location of mutations within the KRT9 rod domain highlights its importance in keratin heterodimerization and skin integrity.
- Different KRT9 mutations may lead to variations in hyperkeratosis, specifically affecting palms and soles.